Postsurgical complication risk seen in IBD patients taking anti-TNF drugs

05/6/2013 | Medscape (free registration)

Patients who take drugs that block tumor necrosis factor alpha have a slightly higher risk of complications following surgery to treat inflammatory bowel disease, Canadian researchers reported. Dr. John Marshall of McMaster University said the study should not change physician practice, but should serve as a caution to doctors and patients that they must weigh all the risks and benefits of surgery for IBD.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ